Xanthoma disseminatum is a non-familial disorder of non-Langerhans cell origin or a class II histiocytosis with unknown etiology, with just over 100 cases reported in the literature. Because of the rarity of this disease, there is no established treatment. We studied clinical manifestations and different treatments of xanthoma disseminatum from a series of cases, including our own patient. We studied 15 articles on treatment of xanthoma disseminatum. Local treatment with cryotherapy, radiotherapy, surgery, and carbon dioxide lasers have been attempted with various results. Systemic medication with peroxisome proliferator-activated gamma receptors, statins, fenofibrate, chlorodeoxyadenosine, cyclophosphamide, doxycycline, and cyclosporine h...
Two case studies of two dermatological patients are described. The first patient, suffering from acn...
Eur J Dermatol. 2001 Sep-Oct;11(5):458-62. Cutaneous necrobiotic xanthogranuloma (NXG)--successfull...
Background Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogr...
Xanthoma disseminatum is a non-familial disorder of non-Langerhans cell origin or a class II histioc...
Xanthoma disseminatum is a rare, benign, non-Langerhans´ cell histiocytic disorder of unknown etiolo...
SUMMARY: Xanthoma disseminatum is a rare normolipemic histiocytic disorder of non-Langerhans cell or...
Xanthoma disseminatum (XD) is a rare mucocutaneous xanthoma nowadays classified as a benign non-Lang...
Artículo de publicación ISIA young male presented with panhypopituitarism (including diabetes insip...
Introduction: Xanthoma disseminatum (XD) is a rare, benign, non-Langerhans cell histiocytic disorde...
Review on Disseminated Juvenile Xanthogranuloma, with data on clinics, and the genes involved
Xanthoma disseminatum (XD) is a rare benign mucocutaneous xanthomatosis that is classified as a beni...
A 49-year-old man diagnosed with metabolic syndrome (MetS) was referred to us for treatment of xanth...
A 60-year-old immunocompetent lady with disseminated primary cutaneous histoplasmosis is reported. H...
findings in a patient with an intracranial mass diagnosed as xanthoma disseminatum (XD). The mass de...
Juvenile xanthogranuloma represents the most common form of non-Langerhans cell histiocytosis. It is...
Two case studies of two dermatological patients are described. The first patient, suffering from acn...
Eur J Dermatol. 2001 Sep-Oct;11(5):458-62. Cutaneous necrobiotic xanthogranuloma (NXG)--successfull...
Background Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogr...
Xanthoma disseminatum is a non-familial disorder of non-Langerhans cell origin or a class II histioc...
Xanthoma disseminatum is a rare, benign, non-Langerhans´ cell histiocytic disorder of unknown etiolo...
SUMMARY: Xanthoma disseminatum is a rare normolipemic histiocytic disorder of non-Langerhans cell or...
Xanthoma disseminatum (XD) is a rare mucocutaneous xanthoma nowadays classified as a benign non-Lang...
Artículo de publicación ISIA young male presented with panhypopituitarism (including diabetes insip...
Introduction: Xanthoma disseminatum (XD) is a rare, benign, non-Langerhans cell histiocytic disorde...
Review on Disseminated Juvenile Xanthogranuloma, with data on clinics, and the genes involved
Xanthoma disseminatum (XD) is a rare benign mucocutaneous xanthomatosis that is classified as a beni...
A 49-year-old man diagnosed with metabolic syndrome (MetS) was referred to us for treatment of xanth...
A 60-year-old immunocompetent lady with disseminated primary cutaneous histoplasmosis is reported. H...
findings in a patient with an intracranial mass diagnosed as xanthoma disseminatum (XD). The mass de...
Juvenile xanthogranuloma represents the most common form of non-Langerhans cell histiocytosis. It is...
Two case studies of two dermatological patients are described. The first patient, suffering from acn...
Eur J Dermatol. 2001 Sep-Oct;11(5):458-62. Cutaneous necrobiotic xanthogranuloma (NXG)--successfull...
Background Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogr...